ResearcherUniversity Health NetworkActive in the last 2 years
Kazeera Aliar
Matched on ORCID iD 0000-0003-1499-1020; OpenAlex author ID A5069158861. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer Co-author DOI 10.64898/2026.10.06.756936↗
- Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
- Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic canc… Co-author DOI 10.1002/path.6199↗
- Spatially confined sub-tumor microenvironments in pancreatic cancer. Co-author DOI 10.1016/j.cell.2021.09.022↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Barbara T. Grünwald · 4 shared papers, 2021–2026 · strength 0.63
- Paper Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic canc… DOI 10.64898/2026.10.06.756936↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associa… DOI 10.1002/path.6199↗
- Rama Khokha · 3 shared papers, 2021–2025 · strength 0.44
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associa… DOI 10.1002/path.6199↗
- Paper Spatially confined sub-tumor microenvironments in pancreatic cancer. DOI 10.1016/j.cell.2021.09.022↗
- Elisabeth Heßmann · 2 shared papers, 2025–2026 · strength 0.38
- Paper Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic canc… DOI 10.64898/2026.10.06.756936↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Niklas Krebs · 2 shared papers, 2023–2025 · strength 0.34
- Faiyaz Notta · 2 shared papers, 2021–2026 · strength 0.29
- Sandra Elisabeth Fischer · 2 shared papers, 2021–2023 · strength 0.25
- Steve Gallinger · 2 shared papers, 2021–2023 · strength 0.25
- Madeleine Dorsch · 1 shared paper, 2026 · strength 0.20
- Barbara M. Grüner · 1 shared paper, 2026 · strength 0.20
- Laura Godfrey · 1 shared paper, 2026 · strength 0.20
- Günter Schneider · 1 shared paper, 2026 · strength 0.20
- John P. Neoptolemos · 1 shared paper, 2026 · strength 0.20
- Jens Thomas Siveke · 1 shared paper, 2026 · strength 0.20
- Argyris Papantonis · 1 shared paper, 2025 · strength 0.18
- Elisa Espinet Espinet · 1 shared paper, 2025 · strength 0.18
- Shiv K. Singh · 1 shared paper, 2025 · strength 0.18
- Uday Kishore · 1 shared paper, 2025 · strength 0.18
- Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
- Andreas Trumpp · 1 shared paper, 2025 · strength 0.18
- Laura Urbach · 1 shared paper, 2025 · strength 0.18
- Lukas Klein · 1 shared paper, 2025 · strength 0.18
- Mengyu Tu · 1 shared paper, 2025 · strength 0.18
- Rebecca Diya Samuel · 1 shared paper, 2025 · strength 0.18
- Volker Ellenrieder · 1 shared paper, 2025 · strength 0.18
- Melanie Boerries · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.